HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katrine Melhus Selected Research

JNJ-7706621

1/2019The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37-Targeted Radioimmunotherapy in Activated B Cell Like Diffuse Large B Cell Lymphoma Cell Lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katrine Melhus Research Topics

Disease

1Epilepsy (Aura)
01/2019
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2019
1Neoplasms (Cancer)
01/2019
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2019

Drug/Important Bio-Agent (IBA)

1JNJ-7706621IBA
01/2019
1tetulomab tetraxetan lu-177IBA
01/2019
1Histone Deacetylases (Histone Deacetylase)IBA
01/2019
1Phosphotransferases (Kinase)IBA
01/2019
1Immunoconjugates (Immunoconjugate)IBA
01/2019
1Histone Deacetylase InhibitorsIBA
01/2019

Therapy/Procedure

1Radioimmunotherapy
01/2019